Shanghai MicroPort MedBot (Group) (HKG:2252) booked 249.7 million yuan in attributable loss for 2025, 61% lower than the 642.4 million loss recorded in 2024, according to a Hong Kong bourse filing Thursday.
Shares of the surgical robot manufacturer gained over 3% in morning trade Friday.
Loss per share was 0.24 yuan, compared with 0.66 yuan in the prior year.
Revenue more than doubled to 551.1 million yuan from 257.2 million yuan in 2024.